Chopas James George 4
4 · Apellis Pharmaceuticals, Inc. · Filed Jan 21, 2025
Insider Transaction Report
Form 4
Chopas James George
VP/Chief Accounting Officer
Transactions
- Award
Common Stock
2025-01-21+12,591→ 49,234 total - Sale
Common Stock
2025-01-17$29.96/sh−715$21,420→ 36,643 total
Footnotes (2)
- [F1]This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2025.
- [F2]This represents a Restricted Stock Unit award granted on January 21, 2025 that vest 25% annually over four years from grant date subject to continued service.